Thomas JS - Search Results

1

Ligand-dependent coactivation of the human bile acid receptor FXR by the peroxisome proliferator-activated receptor gamma coactivator-1alpha.

Savkur RS, Thomas JS, Bramlett KS, Gao Y, Michael LF, Burris TP. Savkur RS, et al. Among authors: thomas js. J Pharmacol Exp Ther. 2005 Jan;312(1):170-8. doi: 10.1124/jpet.104.072124. Epub 2004 Aug 25. J Pharmacol Exp Ther. 2005. PMID: 15329387

2

A natural product ligand of the oxysterol receptor, liver X receptor.

Bramlett KS, Houck KA, Borchert KM, Dowless MS, Kulanthaivel P, Zhang Y, Beyer TP, Schmidt R, Thomas JS, Michael LF, Barr R, Montrose C, Eacho PI, Cao G, Burris TP. Bramlett KS, et al. Among authors: thomas js. J Pharmacol Exp Ther. 2003 Oct;307(1):291-6. doi: 10.1124/jpet.103.052852. Epub 2003 Jul 31. J Pharmacol Exp Ther. 2003. PMID: 12893846

3

T0901317 is a dual LXR/FXR agonist.

Houck KA, Borchert KM, Hepler CD, Thomas JS, Bramlett KS, Michael LF, Burris TP. Houck KA, et al. Among authors: thomas js. Mol Genet Metab. 2004 Sep-Oct;83(1-2):184-7. doi: 10.1016/j.ymgme.2004.07.007. Mol Genet Metab. 2004. PMID: 15464433

4

A chemical switch regulates fibrate specificity for peroxisome proliferator-activated receptor alpha (PPARalpha ) versus liver X receptor.

Thomas J, Bramlett KS, Montrose C, Foxworthy P, Eacho PI, McCann D, Cao G, Kiefer A, McCowan J, Yu KL, Grese T, Chin WW, Burris TP, Michael LF. Thomas J, et al. J Biol Chem. 2003 Jan 24;278(4):2403-10. doi: 10.1074/jbc.M209629200. Epub 2002 Nov 18. J Biol Chem. 2003. PMID: 12441342 Free article.

5

Molecular determinants of LXRalpha agonism.

Wang M, Thomas J, Burris TP, Schkeryantz J, Michael LF. Wang M, et al. J Mol Graph Model. 2003 Nov;22(2):173-81. doi: 10.1016/S1093-3263(03)00159-1. J Mol Graph Model. 2003. PMID: 12932788

6

Real-World Incidence of Anaplastic Lymphoma Kinase alterations in Hispanics with Non-Small Cell Lung Cancer at a Large Academic Institution in Los Angeles.

Poei D, Ali S, Thomas JS, Nieva JJ, Hsu RC. Poei D, et al. Among authors: thomas js. Cancer Res Commun. 2025 Jan 14. doi: 10.1158/2767-9764.CRC-24-0504. Online ahead of print. Cancer Res Commun. 2025. PMID: 39807831 Free article.

7

Precision medicine for patients with salivary gland neoplasms: Determining the feasibility of implementing a next-generation sequencing-based RNA assay in a hospital laboratory.

Sura GH, Hsu J, Mody DR, Thomas JS. Sura GH, et al. Among authors: thomas js. Cytojournal. 2024 Nov 21;21:48. doi: 10.25259/Cytojournal_152_2024. eCollection 2024. Cytojournal. 2024. PMID: 39737124 Free PMC article.

8

CALR frameshift mutation detection in myeloproliferative neoplasms by microfluidic chip analysis.

Greenwood MP, Newton KM, Pepper KL, Hendrickson HL, Olsen RJ, Thomas JS. Greenwood MP, et al. Among authors: thomas js. Lab Med. 2024 Dec 24:lmae096. doi: 10.1093/labmed/lmae096. Online ahead of print. Lab Med. 2024. PMID: 39719677

9

Assessing the predictive role of platelet-lymphocyte ratio in EGFR-mutated non-small cell lung cancer patients treated with tyrosine kinase inhibitors: an analysis across TKI generations.

Cooper R, Ramaswami D, Thomas JS, Nieva JJ, Hsu R. Cooper R, et al. Among authors: thomas js. Discov Oncol. 2024 Nov 21;15(1):689. doi: 10.1007/s12672-024-01606-9. Discov Oncol. 2024. PMID: 39570469 Free PMC article.

10

From rounds to retweets: A digital media fellowship perspective.

Glatz C, Suileman M, Thomas JS, Tran P, Shah SS, Wray CM. Glatz C, et al. Among authors: thomas js. J Hosp Med. 2024 Nov 20. doi: 10.1002/jhm.13557. Online ahead of print. J Hosp Med. 2024. PMID: 39565009 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters